GeneralConnection.com ➔ Dictionary
Dictionary Search

enbrel

Synonyms

Noun

1. etanercept

2. Enbrel, anti-TNF compound

Usage
After Colorado put a price cap on its drug, Amgen sued the state board that did it. Again. - The Colorado Sun
Median price of Enbrel in selected countries in 2022 (in U.S. dollars) - Statista
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times
Medicare coverage for Enbrel: Costs, eligibility, and more - Medical News Today
Leading Companies Consolidating Their Presence in the Enbrel Mini Market - openPR.com
States fed up with high drug prices are cracking down - The Washington Post
Colorado becomes first state to cap prescription drug prices, starting with Enbrel - Denver7
Litigation over State Attempts to Lower Drug Costs: Prescription Drug Affordability Boards (PDABs) - Every CRS Report
Colorado becomes first state to cap price of prescription drug - Colorado Newsline
Amgen sues Colorado over state’s first-in-the-nation price ceiling on arthritis drug Enbrel - The Denver Post
Enbrel Kidney Side Effects Continue To Be Reported After FDA Glomerulonephritis Warning - AboutLawsuits.com
Colorado Adopts First State Payment Cap for Amgen’s Enbrel (1) - Bloomberg Law News
Sandoz Mulls Appeal As US Court Dismisses Amgen Enbrel Antitrust Complaint - Citeline News & Insights
Sandoz's Case Against Amgen Over Enbrel Biosimilar Tossed - Law360
Amgen gets quick appeal in CareFirst's US case over Enbrel - MLex
Colorado just became the first state to cap the price of a prescription drug. What comes next is uncertain. - The Colorado Sun
Amgen revenue from Enbrel by region 2011-2025 - Statista
Competitive Landscape: Key Market Leaders and New Entrants in the Enbrel Market - openPR.com
Colorado sets first-in-the-nation price ceiling on a prescription drug - The Denver Post
Pharmaceutical brand: Enbrel - Statistics & Facts - Statista
Sandoz Appealing Ruling Over Amgen's Enbrel Biosimilar - Law360
Did Pfizer Really Hide Info About a Drug That "Could Prevent Alzheimer’s?" Not So Fast, Say Researchers - Being Patient
AAM Comments on Colorado PDAB Pricing Announcement - Association for Accessible Medicines
After Youngkin’s veto, lawmakers hope Spanberger will warm to cost-cutting prescription drug board - Virginia Mercury
Safety and Efficacy of Perispinal Etanercept for Chronic Stroke - Neurology® Journals
Colorado prescription board votes to limit cost of rheumatoid arthritis drug - Colorado Politics
Drugmaker sues Colorado over first of its kind law setting price ceiling on drug - KUSA.com
Amgen gets quick appeal in CareFirst’s US antitrust case over Enbrel - MLex
Colorado board makes first-in-the-nation move by setting a payment limit on an Amgen drug - statnews.com
Society of Rheumatology Welcomes Reimbursement of Enbrel Biosimilar in Poland - NAVLIN DAILY
Biocon Biologics launches Nepexto, a Biosimilar to Enbrel (Etanercept), in Australia - BioSpectrum Asia
Pfizer Knew Its Drug Could Prevent Alzheimer’s. They Did Nothing About It, Says Post - Being Patient
Amgen Inc. Stock (US0311621009): Reports Strong Q1 2026 Results with Revenue Beat - AD HOC NEWS
Drug Savings Doubted for Colorado as State Nears First Pay Cap - Bloomberg Law News
Biocon Biologics ‘Strategically’ Expands Enbrel Biosimilar With A Launch In Australia - Citeline News & Insights
Canadian RWE Shows Comparable Outcomes Between Etanercept Biosimilars, Originator - Center for Biosimilars
Arrotex & Pfizer Partner on Etanercept in Australia - Pearce IP
Amgen Beat Q4 Estimates, But Some Flagship Drugs Slipped - Finimize
Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season - TradingView
Stelara and Enbrel Chosen for IRA Price Negotiation - Center for Biosimilars
Lupin and Mylan Launch Nepexto®, Biosimilar Etanercept in Germany - Lupin | Press Release - lupin.com
Enbrel Biosimilar Works Well, Yet Some Patients Still Prefer the Originator Drug - CreakyJoints
Amgen Launches The ENBREL Mini™ Single-Dose Prefilled Cartridge With AutoTouch™ Reusable Autoinjector That Is Ergonomically Designed For Patients - Amgen
Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit - Pharmaceutical Technology
Comparing Rheumatoid Arthritis Treatments: Enbrel vs. Humira - Healthline
A three-decade monopoly: How Amgen built a patent thicket around its top-selling drug - BioPharma Dive
Prescription Drug Affordability Board Activity, August 2025 - Partnership for Safe Medicines
Arrotex, Pfizer team up on Enbrel - Pharmacy Daily
Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel - Fierce Pharma
Federal judge dismisses drug company’s suit challenging Colorado prescription affordability board - The Colorado Sun
Amgen Launches The ENBREL Mini™ Single-Dose Prefilled Cartridge With AutoTouch™ Reusable Autoinjector That Is Ergonomically Designed For Patients - PR Newswire
Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the year - Fierce Pharma
Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma
Enbrel cost 2026: Coupons and more - Medical News Today
Arrotex and Pfizer forge strategic pharmacy partnership for ENBREL in Australia - PharmaDispatch
Pharmaceutical company Amgen sues Colorado over price-setting prescription drug board - The Colorado Sun
Etanercept (Enbrel) Associated Inflammatory Eye Disease: Case Report and Review of the Literature - ARVO Journals
Amgen Receives Victory in Arthritis Drug Enbrel Case - Docwire News
What Happens When an Anti-TNF Fails for RA - Arthritis Foundation
Colorado prescription drug board declares Enbrel unaffordable in national first - The Denver Post
Etanercept biosimilars delayed until 2029 in US - Generics and Biosimilars Initiative
Amgen wins Enbrel drug patent appeal - Axios
Letter: Drug price negotiations changed my life - Bangor Daily News
BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in the European Union - Biogen
Stopping Enbrel Risky in Established RA - MedPage Today
Blockbuster Biologic Enbrel Will Continue As A Monopoly For Another 8 Years - Forbes
Amgen Wins Appeals Court Ruling Upholding Patents on Enbrel (3) - Bloomberg Law News
Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions (Published 2016) - The New York Times
US supreme court ends Sandoz–Amgen biosimilar dispute - Chemistry World
Success for Bioepis as FDA approves a second Enbrel biosimilar - BioProcess International
Pfizer’s Enbrel approved in the EU for rare inflammatory disease - BioPharma Dive
Novartis challenge to Amgen’s Enbrel patents ends at Supreme Court’s door - BioPharma Dive
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions - PR Newswire
Enbrel Mini With AutoTouch Now Available - Medical Professionals Reference
Enbrel and the Autoimmune Era - The Atlantic
Enbrel Stays Above the Biosimilar Fray, but Humira Biosimilars May Nip at its Heels - Managed Healthcare Executive
Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world? - The Washington Post
First Head-to-Head Trial of a TNF Inhibitor Versus Methotrexate Monotherapy in Psoriatic Arthritis Shows ENBREL® (Etanercept) Monotherapy and Combination Therapy Both Superior to Methotrexate - PR Newswire
Amgen and PBM Forge Outcomes-Based Agreement for Enbrel Ahead of Biosimilar Competition - Center for Biosimilars
The Little-Known Way Pharma Companies Hook People On Their Costly Drugs - Time Magazine
Amgen’s quarterly results top expectations despite Enbrel sales decline - MarketWatch
Biogen Announces Benepali™ (Etanercept) is the First Biosimilar of Enbrel® to Receive a Positive Opinion from CHMP - Biogen
Amgen, facing potential Enbrel price cap in Colorado, takes state's new drug affordability board to court - Fierce Pharma
Biosimilars of etanercept - Generics and Biosimilars Initiative
Pfizer Reports Continued Weakness for Enbrel in Europe - Center for Biosimilars
Eticovo, a Biosimilar to Enbrel, Gets FDA Approval - Dermatology Advisor
Agency Press Release Page - CT.GOV-Connecticut's Official State Website (.gov)
U.S. Supreme Court snubs Novartis appeal over arthritis drug Enbrel - Reuters
Amgen wins latest round in legal tussle over Enbrel patents - pharmaphorum
Amgen strikes Enbrel 'outcomes' contract with Harvard Pilgrim - Fierce Pharma
Etanercept as Monotherapy in Patients with Psoriasis - The New England Journal of Medicine
US Supreme Court rejects Enbrel patent challenge from Sandoz - Generics and Biosimilars Initiative
Ustekinumab, Etanercept and Natalizumab Biosimilars Up for July PBS-Listing - Pearce IP
India's Cipla sets sights on Avastin, Herceptin and Enbrel - Nature
Amgen's Enbrel fends off biosimilar threat—and heads toward blockbuster superstardom - Fierce Pharma
Biosimilar Etanercept Similar to Enbrel in Persistence of Treatment, Cost Savings for Patients With RA - Center for Biosimilars
Pfizer Did Not Pursue Possible Evidence of Enbrel Helping with Alzheimer's Due to Low Chance of Clinical Success - BioSpace
Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein - Fierce Pharma
Is It Safe to Taper Biologics in Rheumatoid Arthritis Once You Achieve Low Disease Activity? Here’s What a New Study Says About It - CreakyJoints
Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar - PR Newswire
Foreign Language Equivalents
Foreign Language Equivalents of 'enbrel'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
enbel,   envrel,   ebrel,   enbtel,   enbre,   enrel,   ennrel,   enbrrel,   enbrl,   enbrrl,   enbreel,   enrbel,   enbrle,   rnbrel,   enbeel,   ebbrel,   ennbrel,   enbrwl,   nbrel,   enbrell,   eenbrel,   wnbrel,   enbrek,   nebrel,   enbre;,   ebnrel,   embrel,   enbbrel,   enberl
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z